PT941082E - Nova utilizacao para derivados de 1,3-propanodiol - Google Patents

Nova utilizacao para derivados de 1,3-propanodiol

Info

Publication number
PT941082E
PT941082E PT97951219T PT97951219T PT941082E PT 941082 E PT941082 E PT 941082E PT 97951219 T PT97951219 T PT 97951219T PT 97951219 T PT97951219 T PT 97951219T PT 941082 E PT941082 E PT 941082E
Authority
PT
Portugal
Prior art keywords
propanodiol
derivatives
new use
optionally substituted
chem
Prior art date
Application number
PT97951219T
Other languages
English (en)
Inventor
Cottens Sylvain
Hof Robert Paul
Wenger Roland
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Publication of PT941082E publication Critical patent/PT941082E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Light Receiving Elements (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT97951219T 1996-11-19 1997-11-17 Nova utilizacao para derivados de 1,3-propanodiol PT941082E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9624038.7A GB9624038D0 (en) 1996-11-19 1996-11-19 Organic compounds

Publications (1)

Publication Number Publication Date
PT941082E true PT941082E (pt) 2004-12-31

Family

ID=10803173

Family Applications (2)

Application Number Title Priority Date Filing Date
PT02025422T PT1312359E (pt) 1996-11-19 1997-11-17 Utilização de compostos 1, 3-propanodiol
PT97951219T PT941082E (pt) 1996-11-19 1997-11-17 Nova utilizacao para derivados de 1,3-propanodiol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT02025422T PT1312359E (pt) 1996-11-19 1997-11-17 Utilização de compostos 1, 3-propanodiol

Country Status (25)

Country Link
US (3) US6274629B1 (pt)
EP (2) EP1312359B1 (pt)
JP (2) JP4004070B2 (pt)
CN (2) CN1293876C (pt)
AT (2) ATE275947T1 (pt)
AU (1) AU728420B2 (pt)
BR (1) BR9713105A (pt)
CA (1) CA2270952C (pt)
CZ (1) CZ174999A3 (pt)
DE (2) DE69738033T2 (pt)
DK (1) DK1312359T3 (pt)
ES (2) ES2227726T3 (pt)
GB (1) GB9624038D0 (pt)
HK (1) HK1022639A1 (pt)
HU (1) HUP0000343A3 (pt)
ID (1) ID21568A (pt)
IL (1) IL129824A (pt)
NO (1) NO992259D0 (pt)
NZ (1) NZ335629A (pt)
PL (1) PL190348B1 (pt)
PT (2) PT1312359E (pt)
RU (1) RU2217136C2 (pt)
SI (1) SI1312359T1 (pt)
SK (1) SK284806B6 (pt)
WO (1) WO1998022100A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69923579T2 (de) 1998-11-11 2006-01-12 Novartis Ag Herstellung von 2-amino-2(2-(4-alkylphenyl)äthyl)propan-1,3-diolen
SK8332002A3 (en) * 1999-12-16 2003-04-01 Teva Pharma Novel processes for making- and a new crystalline form of leflunomide
AU2001285331B2 (en) 2000-08-31 2006-04-06 Merck & Co., Inc. Phosphate derivatives as immunoregulatory agents
CN100479814C (zh) * 2001-02-22 2009-04-22 诺瓦提斯公司 促淋巴细胞归巢剂在制备用于治疗移植物功能恢复延迟的药物中的用途
CA2444278C (en) * 2001-04-20 2011-11-22 Debiopharm S.A. Modified cyclosporine which can be used as a pro-drug and use thereof
EP1429845B1 (en) * 2001-06-08 2009-03-11 Novartis AG Treatment or prophylaxis of insulin-producing cell graft rejection
GB0117921D0 (en) * 2001-07-23 2001-09-12 Novartis Ag Organic compounds
US7780993B2 (en) * 2001-09-07 2010-08-24 Yeda Research And Development Co. Ltd. Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
US20040136972A1 (en) * 2001-09-07 2004-07-15 Yeda Research And Development Co. Ltd. Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
AU2003202495B2 (en) 2002-01-11 2006-07-20 Sankyo Company, Limited Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
GB0217777D0 (en) * 2002-07-31 2002-09-11 Novartis Ag Organic compounds
IL165425A0 (en) * 2004-11-28 2006-01-15 Yeda Res & Dev Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
PE20150676A1 (es) 2003-04-08 2015-05-17 Novartis Ag Composicion farmaceutica que contiene un agonista del receptor s1p y un alcohol de azucar
EP1484057A1 (en) * 2003-06-06 2004-12-08 Aventis Pharma Deutschland GmbH Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
US7524887B2 (en) 2003-06-06 2009-04-28 Sanofi-Aventis Deutschland Gmbh 2-amino-1,3-propanediol compounds for the treatment of acute pain
US7838562B2 (en) * 2003-06-24 2010-11-23 University Of Connecticut Methods of inhibiting vascular permeability and apoptosis
US7074659B2 (en) * 2003-11-13 2006-07-11 Volterra Semiconductor Corporation Method of fabricating a lateral double-diffused MOSFET (LDMOS) transistor
NZ549162A (en) 2004-02-24 2009-12-24 Sankyo Co Amino-pyrrol alcohol compounds
US20080096972A1 (en) * 2004-07-30 2008-04-24 Thitiwan Buranachokpaisan Compound formulations of 2-amino-1, 3-propanediol compounds
PL1961734T3 (pl) 2005-12-15 2012-02-29 Mitsubishi Tanabe Pharma Corp Związek aminowy i jego zastosowanie do celów medycznych
JO3177B1 (ar) 2011-04-01 2018-03-08 Novartis Ag تركيبات تتالف من 2-أمينو-2- [ 2- ( 4- أكتيل فينيل ) إثيل ] بروبان - 3, 1- ديول
RU2496486C1 (ru) 2012-07-11 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция с улучшенной сыпучестью, лекарственное средство, способ получения и применение
KR102255357B1 (ko) * 2013-03-05 2021-05-24 바이오콘 리미티드 2-아미노-1,3-프로판디올 화합물 및 이의 염의 제조방법
US20180250235A1 (en) 2015-09-18 2018-09-06 Sanovel Ilac Sanayi Ve Ticaret A.S. Fingolimod capsule composition
EP4353709A1 (en) * 2021-05-31 2024-04-17 Shanghai Yonsun Biotechnology Co., Ltd. Pharmaceutical salt of fingolimod, preparation method therefor, pharmaceutical composition containing same and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904679A (en) * 1972-05-23 1975-09-09 Upjohn Co 15-Methyl and 15-ethyl prostaglandin F{HD 2{331 {0 {B analogs
DK0605442T3 (da) * 1991-07-25 2003-08-04 Idec Pharma Corp Rekombinante antistoffer til human terapi
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5747034A (en) * 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
DE122011100012I1 (de) * 1992-10-21 2011-10-20 Mitsubishi Tanabe Pharma Corp 2-Amino-1, 3-propandiolverbindung und immunosuppressium.
SK282225B6 (sk) * 1995-12-28 2001-12-03 Welfide Corporation Použitie 2-amino-2[2-(4-oktylfenyl)etyl]-propán-1,3-diolu alebo jeho farmaceuticky prijateľnej adičnej soli s kyselinou na výrobu farmaceutického prostriedku
JP2002241272A (ja) * 1996-07-18 2002-08-28 Mitsubishi Pharma Corp 医薬処方組成物
US6476004B1 (en) * 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
PT990440E (pt) * 1997-02-27 2009-02-05 Novartis Ag Composição farmacêutica compreendendo 2-amino-2-[2-(4-octilfenil)etil]propano-1,3-diol, uma lecitina e um sacárido

Also Published As

Publication number Publication date
US6274629B1 (en) 2001-08-14
DE69730727T2 (de) 2005-09-22
US6486209B2 (en) 2002-11-26
PT1312359E (pt) 2007-11-09
SK284806B6 (sk) 2005-11-03
AU5483198A (en) 1998-06-10
JP2001503780A (ja) 2001-03-21
EP0941082B1 (en) 2004-09-15
SK65999A3 (en) 1999-12-10
EP1312359A3 (en) 2004-01-02
AU728420B2 (en) 2001-01-11
CN1515253A (zh) 2004-07-28
ID21568A (id) 1999-06-24
EP1312359B1 (en) 2007-08-15
ES2289041T3 (es) 2008-02-01
CA2270952A1 (en) 1998-05-28
IL129824A (en) 2003-07-31
HK1022639A1 (en) 2000-08-18
DE69738033D1 (de) 2007-09-27
HUP0000343A2 (hu) 2000-12-28
CN1293876C (zh) 2007-01-10
WO1998022100A3 (en) 1998-06-25
NO992259L (no) 1999-05-10
US20010056124A1 (en) 2001-12-27
CN1237906A (zh) 1999-12-08
CZ174999A3 (cs) 1999-08-11
NZ335629A (en) 2001-09-28
SI1312359T1 (sl) 2008-08-31
BR9713105A (pt) 2000-04-11
ATE275947T1 (de) 2004-10-15
IL129824A0 (en) 2000-02-29
EP0941082A2 (en) 1999-09-15
RU2217136C2 (ru) 2003-11-27
CA2270952C (en) 2007-09-18
JP4004070B2 (ja) 2007-11-07
DE69730727D1 (de) 2004-10-21
JP2004256554A (ja) 2004-09-16
GB9624038D0 (en) 1997-01-08
PL333463A1 (en) 1999-12-20
PL190348B1 (pl) 2005-11-30
EP1312359A2 (en) 2003-05-21
US20030069315A1 (en) 2003-04-10
DK1312359T3 (da) 2007-10-08
NO992259D0 (no) 1999-05-10
ES2227726T3 (es) 2005-04-01
HUP0000343A3 (en) 2001-06-28
CN1146411C (zh) 2004-04-21
WO1998022100A2 (en) 1998-05-28
ATE369846T1 (de) 2007-09-15
DE69738033T2 (de) 2008-04-30

Similar Documents

Publication Publication Date Title
PT941082E (pt) Nova utilizacao para derivados de 1,3-propanodiol
PT870768E (pt) Derivados azaindole-etilamina como agentes de ligacao nicotinicos aos receptores de acetilcolina
ATE125539T1 (de) 1,4-benzothiazedinderivat.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
PE34996A1 (es) Nuevo derivado de pirrocarbazol
AU635445B2 (en) New compounds
LV10076A (lv) Aizvietoti beta- diketoni
MX170732B (es) Composicion de derivados de succinimida y su uso
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
DE69020323D1 (de) Inhibitoren der LTB4-Synthese.
ATE85336T1 (de) Ergolin-derivate.
DE69103985D1 (de) N-Alkylthiazolidinderivate.
ES2100755T3 (es) Derivados de imidazopiridina y procedimiento para su preparacion.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.